CIK 0001158780
- Non-accelerated filer
- Smaller reporting company
Pluri Inc.
Sign in to watch- Ticker
- PLUR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 980351734
- Phone
- +972 747107171
- Business address
- MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA, Israel
- Former names
- PLURISTEM THERAPEUTICS INC, PLURISTEM LIFE SYSTEMS INC, AI SOFTWARE INC
- 4 Grant or award Director acquired 65,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 35,000 shares (grant or award)
- 4 Grant or award Director acquired 35,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Open-market sale Director sold 67,244 shares at an average $3.27 ($219,883)
- 4 Open-market sale Director sold 52,000 shares at an average $3.07 ($159,891)
- 4 Grant or award Director acquired 85,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 85,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 85,000 shares (grant or award)
- 4 Grant or award CEO & Chairman acquired 350,000 shares (grant or award)
- 4 Grant or award CFO, Executive Vice President acquired 250,000 shares (grant or award)
- 4 Open-market buy Director bought 63,902 shares at an average $3.04 ($194,206)
- 4 Exercise or conversion Director acquired 27,500 shares (option exercise)
- 4 Open-market sale CEO & Chairman sold 33,853 shares at $5.00 ($169,265)
- 4 Open-market sale Chief Financial Officer sold 16,927 shares at $5.00 ($84,635)
Page 10 of 18 · 352 filings